Recommendations for Quicker CTA Negotiation
Whether in Canada or any other country it is no secret that executing Clinical Trial Agreements (CTAs) is often the…
Overcome Today’s New Enrollment Challenges
Choose Your Specialized CRO Partner Well The global clinical trials market is expected to reach $69.8 billion US by 2027,…
CRAs Play a Supporting Role in Patient-Centric Trials
There is an ever-present desire in the clinical trial industry to practice ‘patient-centricity’. This practice is featured predominantly during the…
Collaborative Vendor Teaming for Better Oncology Trial Results – Real World Evidence
Workplace collaboration requires a willingness to find solutions to problems, together with others. Which means that any successful collaborative vendor…
Going Above-and-Beyond – What Can Your Specialized Oncology CRO Do for You?
Clinical research is a growing and fascinating field marked by increasing complexity and competitive surroundings. CROs can help their Sponsors…
Oncology Trial Investigators and Participants – Where to Look?
Global Leaders in Number of Clinical Trial Participants Today Clinical research is becoming more complex, with more clinical trials than…
Hassle-Free Site Selection and Study Start-up for Clinical Trials in Canada
It is no secret that Canada’s presence as a key player in the field of pharmaceutical drug development is rapidly…
Do Data Entry Issues & Backlog Threaten Your Clinical Trial?
6 Critical Factors for Prevention & Mitigation Collecting clinical data that are accurate, reliable and of high quality is the…
What is Most Important When Conducting Oncology Clinical Research in Canada?
Developing oncology compounds is a constantly evolving process, and with the dramatic rise in costs, and competitive trials, making every…
What to Look for When Selecting a CRO – Real World Evidence
There is a myriad of factors involved in selecting a CRO. Do CRO team members have the necessary therapeutic expertise?…